ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 53 filers reported holding ACUMEN PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $237,791 | +264.3% | 57,299 | +322.2% | 0.00% | – |
| Q2 2023 | $65,281 | -62.0% | 13,572 | -67.9% | 0.00% | – |
| Q1 2023 | $171,746 | +87.2% | 42,302 | +149.0% | 0.00% | – |
| Q4 2022 | $91,751 | -59.6% | 16,991 | -24.9% | 0.00% | – |
| Q3 2022 | $227,000 | +73.3% | 22,617 | -18.9% | 0.00% | – |
| Q2 2022 | $131,000 | -90.0% | 27,886 | -91.7% | 0.00% | – |
| Q1 2022 | $1,307,000 | -40.2% | 334,195 | +3.4% | 0.00% | – |
| Q4 2021 | $2,185,000 | +131.0% | 323,264 | +408.0% | 0.00% | – |
| Q3 2021 | $946,000 | – | 63,635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $18,452 | 5.05% |
| Knollwood Investment Advisory, LLC | 1,678,510 | $9,063,954 | 3.55% |
| GUARDIAN POINT CAPITAL, LP | 300,000 | $1,620,000 | 1.28% |
| GREAT POINT PARTNERS LLC | 1,116,581 | $6,029,537 | 1.18% |
| RA Capital Management | 9,770,773 | $52,762,174 | 1.07% |
| Deep Track Capital, LP | 3,952,000 | $21,340,800 | 0.90% |
| Cheyne Capital Management (UK) LLP | 55,829 | $301,477 | 0.53% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 295,115 | $1,593,621 | 0.46% |
| COMMODORE CAPITAL LP | 498,315 | $2,691 | 0.41% |
| Ikarian Capital, LLC | 254,945 | $1,376,703 | 0.33% |